1. Home
  2. YHC vs SILO Comparison

YHC vs SILO Comparison

Compare YHC & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LQR House Inc. Common Stock

YHC

LQR House Inc. Common Stock

HOLD

Current Price

$0.96

Market Cap

8.7M

ML Signal

HOLD

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$0.45

Market Cap

8.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
YHC
SILO
Founded
2021
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Apparel
Sector
Consumer Staples
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
8.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
YHC
SILO
Price
$0.96
$0.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
332.1K
141.3K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,103,341.00
$72,102.00
Revenue This Year
$69.97
$1.86
Revenue Next Year
$403.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.36
52 Week High
$98.00
$3.37

Technical Indicators

Market Signals
Indicator
YHC
SILO
Relative Strength Index (RSI) 56.28 44.64
Support Level $0.85 $0.45
Resistance Level $1.04 $0.48
Average True Range (ATR) 0.07 0.03
MACD 0.01 0.01
Stochastic Oscillator 68.92 77.68

Price Performance

Historical Comparison
YHC
SILO

About YHC LQR House Inc. Common Stock

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: